Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
3.315
-0.175 (-5.01%)
At close: Jun 29, 2026, 4:00 PM EDT
3.310
-0.005 (-0.15%)
After-hours: Jun 29, 2026, 4:01 PM EDT
Embecta Market Cap
Embecta has a market cap or net worth of $197.26 million as of June 29, 2026. Its market cap has decreased by -66.38% in one year.
Market Cap
197.26M
Enterprise Value
1.39B
1-Year Change
-66.38%
Ranking
Category
Stock Price
$3.32
Market Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $197.26M, a decrease of -92.63%. That is a compound annual growth rate of -45.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 197.26M | -71.96% |
| Dec 31, 2025 | 703.44M | -41.40% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
| Mar 22, 2022 | 2.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anbio Biotechnology | 637.74M |
| AngioDynamics | 558.54M |
| OraSure Technologies | 307.06M |
| Utah Medical Products | 235.52M |
| Sanara MedTech | 218.84M |
| KORU Medical Systems | 204.86M |
| Pro-Dex | 196.26M |
| Nyxoah | 172.57M |